Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2016-05-31 Regulatory Filings
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release dated May 31, 2016, announcing that Pixium Vision received clinical trial approval from the UK Regulatory Authority (MHRA) for its IRIS® II bionic vision system. It details the expansion of the clinical trial to Moorfields Eye Hospital and provides updates on the CE mark process and commercialization expectations. This type of announcement, focusing on regulatory milestones, clinical progress, and business updates outside of routine financial reporting (like 10-K or ER), is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but given the format and content (press release announcing regulatory news), RNS is the most appropriate general category for non-standard, material announcements. It is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG). Since it is a formal announcement of a regulatory event, RNS is the best fit as a catch-all for significant, non-standard regulatory news.
2016-05-31 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated May 31, 2016, announcing that Pixium Vision has received authorization from the UK regulatory authority (MHRA) to evaluate its IRIS® II bionic vision system in a clinical trial setting at Moorfields Eye Hospital in London. The text details the clinical trial, the technology (IRIS® II), and future commercialization plans, including the expected CE marking mid-2016. This type of announcement, focusing on regulatory milestones, clinical trial expansion, and operational updates rather than comprehensive financial results (10-K, IR) or formal voting results (DVA), best fits the category for general regulatory announcements or news releases that don't fit a more specific financial or governance code. Since it is a specific announcement about regulatory approval for a clinical trial, it is not a standard Earnings Release (ER) or Interim Report (IR). It is not a proxy statement (PSI) or a management discussion (MDA). Given the nature of the announcement—a significant operational/regulatory update that is not a formal financial report or a specific insider/dividend notice—it falls under the general Regulatory Filings (RNS) category, which serves as a broad category for important, non-standard corporate news releases.
2016-05-31 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated May 4, 2016, announcing scientific progress regarding the PRIMA implant presented at the ARVO (Association for Research in Vision and Ophthalmology) annual congress. It details preclinical results, quotes the CEO, and lists the specific scientific posters presented. This type of announcement, focusing on research updates, scientific presentations, and general corporate news that isn't a formal financial filing (like 10-K, ER, or IR), fits best under the general category for regulatory announcements or corporate news that doesn't have a more specific code. Since it is an announcement of scientific findings and not a formal financial report, it is not an ER, IR, or 10-K. It is not a management change (MANG), dividend (DIV), or capital change (CAP). Given the context of a press release detailing scientific progress and presentation at a conference, it is most appropriately classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were the slides themselves, but as a press release *about* presentations, RNS is the most suitable general category for non-standard corporate updates.
2016-05-04 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is dated May 4, 2016, and is structured as a press release announcing scientific progress and research findings presented at the ARVO conference. It details preclinical results for the PRIMA implant system and mentions upcoming clinical trials. This format—a news announcement highlighting recent operational or research achievements, often released outside of standard quarterly/annual reporting cycles—is characteristic of a general corporate announcement. Since it is not a formal financial report (10-K, IR, ER), a management discussion (MDA), or a specific regulatory filing like a Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate classification is the general regulatory announcement/press release category, RNS, as it serves as a broad communication to the market about company developments.
2016-05-04 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition document de référence ou de ses actualisations
Report Publication Announcement Classification · 99% confidence The document is a short announcement dated April 28, 2016, stating that Pixium Vision's 'Document de référence 2015' (Reference Document 2015) has been registered with the AMF (Autorité des Marchés Financiers) and is now available on the company's and AMF's websites. The document length is very short (3784 characters) and its primary function is to announce the publication/availability of a formal report ('Document de référence 2015'). According to Rule #2 (The 'MENU VS MEAL' Rule), when a document announces that a report has been published and provides links, it should be classified as a Report Publication Announcement (RPA), not the report itself (which would likely be a 10-K or similar comprehensive filing, though 'Document de référence' often maps to a 10-K equivalent in French regulation, the announcement format dictates RPA). Therefore, the classification is RPA.
2016-04-28 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Earnings Release Classification · 98% confidence The document is titled "Pixium Vision announces its first quarter 2016 financial update and a new date for its Annual General Meeting." It contains key financial highlights for the first quarter of 2016 (Revenues, Cash position) and commentary from the CEO. This structure strongly indicates an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Although it mentions the AGM date change, the primary focus is the quarterly financial update. It is not a comprehensive Interim Report (IR) or Annual Report (10-K), nor is it a transcript (CT) or a formal presentation (IP). Since it is a direct announcement of results, ER is the most appropriate classification. Q1 2016
2016-04-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.